|
Market Cap (1-Jul) $71,840,344 (1,153rd) |
Close (30-Jun) $0.025 |
Volume (30-Jun) 981,823 |
Shortsold (10-Jun) 33,792 (0.00%) (569th) |
|
52w High $0.060 |
52w Low $0.024 |
P/E - |
EPS -0.01 |
PCK released this announcement to the ASX on 7 March 2023, 11:00. The announcement is not marked as price sensitive, and is 6 page(s) in length and 25.82kb in size.
You can view all announcements from PCK and see how they appear on a price chart on the announcements page.
At the date of this announcement, PCK was 0.001% short sold according to ASIC data. It was ranked the 621st most shorted stock on the ASX. It is now ranked as the 569th most shorted stock on the ASX with 0.002% of total shares short sold as of the latest reported data (10 June 2025).
| Other Recent Announcements from PCK | |
|---|---|
| Ethos Laboratories Distribution Agreement | 15 June 2023, 10:52 |
| Investor Presentation Webinar | 2 May 2023, 8:31 |
| Quarterly Investor Webinar - Tuesday 2 May | 28 April 2023, 16:30 |
| Application for quotation of securities - PCK | 7 March 2023, 11:00 |
| Half Yearly Report and Accounts | 28 February 2023, 9:24 |
| Investor Webinar Presentation | 31 January 2023, 9:24 |
| Quarterly Update and Appendix 4C | 31 January 2023, 9:22 |
You must be logged in to post a reply.
PainChek 